Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2008;118:1541-1549
Published online before print September 22, 2008, doi: 10.1161/CIRCULATIONAHA.108.781401
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
118/15/1541    most recent
CIRCULATIONAHA.108.781401v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maron, M. S.
Right arrow Articles by Maron, B. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maron, M. S.
Right arrow Articles by Maron, B. J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Cardiomyopathy
Related Collections
Right arrow Other heart failure
Right arrow Myocardial cardiomyopathy disease
Right arrow CT and MRI
Right arrowRelated Article

(Circulation. 2008;118:1541-1549.)
© 2008 American Heart Association, Inc.


Heart Failure

Prevalence, Clinical Significance, and Natural History of Left Ventricular Apical Aneurysms in Hypertrophic Cardiomyopathy

Martin S. Maron, MD; John J. Finley, MD; J. Martijn Bos, MD; Thomas H. Hauser, MD, MMSc, MPH; Warren J. Manning, MD; Tammy S. Haas, RN; John R. Lesser, MD; James E. Udelson, MD; Michael J. Ackerman, MD, PhD; Barry J. Maron, MD

From the Hypertrophic Cardiomyopathy Center, Division of Cardiology, Tufts Medical Center, Boston, Mass (M.S.M., J.J.F., J.E.U.); Department of Medicine, Pediatrics, and Molecular Pharmacology, Experimental Therapeutics/Divisions of Cardiovascular Diseases and Pediatric Cardiology, and the Mayo Clinic Windland Smith Rice Sudden Death Genomics Laboratory, Mayo Clinic, Rochester, Minn (J.M.B., M.J.A.); Departments of Medicine (Cardiovascular Division) (T.H.H., W.J.M.) and Radiology (W.J.M.), Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass; and Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, Minn (T.S.H., J.R.L., B.J.M.).

Correspondence to Martin S. Maron, MD, Tufts Medical Center, No. 70, 800 Washington St, Boston, MA 02111. E-mail mmaron{at}tuftsmedicalcenter.org

Received March 25, 2008; accepted July 29, 2008.

Background— Hypertrophic cardiomyopathy (HCM) is the most common genetic heart disease characterized by a diverse clinical and phenotypic spectrum. This study reports the prevalence, morphology, clinical course, and management of an underrecognized subgroup of HCM patients with left ventricular apical aneurysms.

Methods and Results— Of 1299 HCM patients, 28 (2%) were identified with left ventricular apical aneurysms, including a pair of identical twins. Aneurysms were recognized at a wide age range (26 to 83 years), including 12 patients (43%) who were ≤50 years of age. Apical aneurysms varied considerably in size (maximum dimension, 10 to 66 mm), were dyskinetic/akinetic with thin rims, and were associated with transmural (and often more extensive) myocardial scarring identified by late gadolinium enhancement cardiovascular magnetic resonance. Apical aneurysms were recognized by echocardiography in only 16 of 28 patients (57%) but by cardiovascular magnetic resonance in the 12 patients undetected by echocardiography. Left ventricular chamber morphology varied; however, 19 patients (68%) showed an "hourglass" contour, with midventricular hypertrophy producing muscular narrowing and intracavitary gradients in 9 patients (74±42 mm Hg). Sarcomeric protein missense mutations known to cause other phenotypic expressions of HCM were present in 3 patients. Over 4.1±3.7 years of follow-up, 12 patients (43%) with left ventricular apical aneurysms experienced adverse disease complications (event rate, 10.5%/y), including sudden death, appropriate implantable cardioverter-defibrillator discharges, nonfatal thromboembolic stroke, and progressive heart failure and death.

Conclusions— Patients with left ventricular apical aneurysms represent an underappreciated subset in the heterogeneous HCM disease spectrum with important clinical implications, often requiring a high index of suspicion and cardiovascular magnetic resonance for identification. Apical aneurysms in HCM are associated with substantial cardiovascular morbidity and mortality and raise novel treatment considerations.


 

CLINICAL PERSPECTIVE


Related Article:

Clinical Summaries
Circulation 2008 118: 1519-1520. [Extract] [Full Text]



This article has been cited by other articles:


Home page
Eur J EchocardiogrHome page
L.K. Williams, M.P. Frenneaux, and R.P. Steeds
Echocardiography in hypertrophic cardiomyopathy diagnosis, prognosis, and role in management
Eur J Echocardiogr, December 1, 2009; 10(8): iii9 - iii14.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. D. Karamitsos, J. M. Francis, S. Myerson, J. B. Selvanayagam, and S. Neubauer
The Role of Cardiovascular Magnetic Resonance Imaging in Heart Failure
J. Am. Coll. Cardiol., October 6, 2009; 54(15): 1407 - 1424.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol ImgHome page
T. Knickelbine, J. R. Lesser, T. S. Haas, E. R. Brandenburg, B. K. Gleason-Han, B. Flygenring, T. F. Longe, R. S. Schwartz, and B. J. Maron
Identification of Unexpected Nonatherosclerotic Cardiovascular Disease With Coronary CT Angiography
J. Am. Coll. Cardiol. Img., September 1, 2009; 2(9): 1085 - 1092.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. V. Sherrid, O. Wever-Pinzon, A. Shah, and F. A. Chaudhry
Reflections of inflections in hypertrophic cardiomyopathy.
J. Am. Coll. Cardiol., July 14, 2009; 54(3): 212 - 219.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. Ando, F. Saporito, and F. Arrigo
Letter by Ando et al Regarding Article, "Prevalence, Clinical Significance, and Natural History of Left Ventricular Apical Aneurysms in Hypertrophic Cardiomyopathy"
Circulation, June 9, 2009; 119(22): e557 - e557.
[Full Text] [PDF]


Home page
CirculationHome page
M. S. Maron, J. J. Finley, J. E. Udelson, J. M. Bos, M. J. Ackerman, T. H. Hauser, W. J. Manning, T. S. Haas, J. R. Lesser, and B. J. Maron
Response to Letter Regarding Article, "Prevalence, Clinical Significance, and Natural History of Left Ventricular Apical Aneurysms in Hypertrophic Cardiomyopathy"
Circulation, June 9, 2009; 119(22): e558 - e558.
[Full Text] [PDF]


Home page
Circ Cardiovasc ImagingHome page
A. S. Flett, M. A. Westwood, L. C. Davies, A. Mathur, and J. C. Moon
The Prognostic Implications of Cardiovascular Magnetic Resonance
Circ Cardiovasc Imaging, May 1, 2009; 2(3): 243 - 250.
[Full Text] [PDF]